For research use only. Not for therapeutic Use.
5-Oxo-Zaleplon is a metabolite of zaleplon, a medication used to treat insomnia. It is formed through the oxidation of the parent drug and retains some pharmacological activity. Understanding the properties and effects of 5-Oxo-Zaleplon is important for pharmacokinetic studies, as it helps elucidate the drug’s metabolism, duration of action, and potential side effects in patients.
Catalog Number | R040013 |
CAS Number | 159225-99-7 |
Synonyms | N-[3-(3-Cyano-4,5-dihydro-5-oxopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethyl-acetamide; Pyrazolo[1,5-a]pyrimidine, Acetamide Deriv.; CL 345905 |
Molecular Formula | C17H15N5O2 |
Purity | ≥95% |
Storage | Store at RT |
IUPAC Name | N-[3-(3-cyano-5-oxo-1H-pyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethylacetamide |
InChI | InChI=1S/C17H15N5O2/c1-3-21(11(2)23)14-6-4-5-12(7-14)15-8-16(24)20-17-13(9-18)10-19-22(15)17/h4-8,10,19H,3H2,1-2H3 |
InChIKey | JWVZREIWNLDSMI-UHFFFAOYSA-N |
SMILES | CCN(C1=CC=CC(=C1)C2=CC(=O)N=C3N2NC=C3C#N)C(=O)C |